NOS2 and breast neoplasm: These observations strongly point to NOS2 as a potential comprehensive driver of aggressive metastatic tumors and further suggest that NOS2 inhibition or blunting of NO/SNO signaling is a potential therapeutic target for basal-like breast tumors.